Literature DB >> 21750933

[Ω-3 fatty acids after myocardial infarction : Alpha Omega Trial].

C von Schacky1, S Nitschmann.   

Abstract

Entities:  

Year:  2011        PMID： 21750933     DOI： 10.1007/s00108-011-2906-4

Source DB:  PubMed          Journal:  Internist (Berl)        ISSN： 0020-9554            Impact factor:   0.743


× No keyword cloud information.
  3 in total

1.  Effect of low doses of n-3 fatty acids on cardiovascular diseases in 4,837 post-myocardial infarction patients: design and baseline characteristics of the Alpha Omega Trial.

Authors:  Johanna M Geleijnse; Erik J Giltay; Evert G Schouten; Janette de Goede; Linda M Oude Griep; Anna M Teitsma-Jansen; Martijn B Katan; Daan Kromhout
Journal:  Am Heart J       Date:  2010-04       Impact factor: 4.749

2.  OMEGA, a randomized, placebo-controlled trial to test the effect of highly purified omega-3 fatty acids on top of modern guideline-adjusted therapy after myocardial infarction.

Authors:  Bernhard Rauch; Rudolf Schiele; Steffen Schneider; Frank Diller; Norbert Victor; Helmut Gohlke; Martin Gottwik; Gerhard Steinbeck; Ulrike Del Castillo; Rudolf Sack; Heinrich Worth; Hugo Katus; Wilhelm Spitzer; Georg Sabin; Jochen Senges
Journal:  Circulation       Date:  2010-11-08       Impact factor: 29.690

Review 3.  Omega-3 dietary supplements and the risk of cardiovascular events: a systematic review.

Authors:  Paul E Marik; Joseph Varon
Journal:  Clin Cardiol       Date:  2009-07       Impact factor: 2.882
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.